Pubblicazioni

Targeting chemotherapy to decondensed H3K27me3-marked chromatin of AML Cells enhances Leukemia suppression

2022 - CANCER RESEARCH

Porazzi, P.; Petruk, S.; Pagliaroli, L.; De Dominici, M.; Deming, D.; Puccetti, M. V.; Kushinsky, S.; Kumar, G.; Minieri, V.; Barbieri, E.; Deliard, S.; Grande, A.; Trizzino, M.; Gardini, A.; Canaani, E.; Palmisiano, N.; Porcu, P.; Ertel, A.; Fortina, P.; Eischen, C. M.; Mazo, A.; Calabretta, B.

Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration

2022 - LEUKEMIA

Cappelli, L. V.; Meggendorfer, M.; Baer, C.; Nadarajah, N.; Hutter, S.; Jeromin, S.; Dicker, F.; Kern, W.; Haferlach, T.; Haferlach, C.; Hollein, A.

Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

2022 - AMERICAN JOURNAL OF HEMATOLOGY

W Beelen, Dietrich; Stelljes, Matthias; RemÃ©nyi, PÃ©ter; Wagner-Drouet, Eva-Maria; Dreger, Peter; Bethge, Wolfgang; Ciceri, Fabio; StÃ¶lzel, Friedrich; JunghanÃ, Christian; Labussiere-Wallet, HÃ©lÃ¨ne; Schaefer-Eckart, Kerstin; U Grigoleit, Goetz; Scheid, Christof; Patriarca, Francesca; Rambaldi, Alessandro; Niederwieser, Dietger; Hilgendorf, Inken; Russo, Domenico; SociÃ©, GÃ©rard; Holler, Ernst; Glass, Bertram; Casper, Jochen; Wulf, Gerald; Basara, Nadezda; Bieniaszewska, Maria; Stuhler, Gernot; Verbeek, Mareike; LA ROCCA, Ursula; Finke, JÃ¼rgen; Benedetti, Fabio; Pichlmeier, Uwe; Klei, Anja; Baumgart, Joachim; Markiewicz, Miroslaw

The role of H3K4 trimethylation in CpG islands hypermethylation in cancer

2021 - BIOMOLECULES

Zardo, G.

Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience

2020 - ANNALS OF HEMATOLOGY

Pepe, S.; Scalzulli, E.; Colafigli, G.; Di Prima, A.; Diverio, D.; Mancini, M.; Latagliata, R.; Martelli, M.; Foa, R.; Breccia, M.

Peripherally inserted central catheter in patients with acute myeloid leukemia. Incidence and risk factors for premature removal

2020 - LEUKEMIA & LYMPHOMA

Bruzzese, A.; Chistolini, A.; Morano, S. G.; Alunni Fegatelli, D.; Micozzi, A.

DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational pattern

2019 - LEUKEMIA

Cappelli, L. V.; Meggendorfer, M.; Dicker, F.; Jeromin, S.; Hutter, S.; Kern, W.; Haferlach, T.; Haferlach, C.; Hollein, A.

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia

2017 - LEUKEMIA

Bernson, E.; Hallner, A.; Sander, F. E.; Wilsson, O.; Werlenius, O.; RydstrÃ¶m, A.; Kiffin, R.; Brune, M.; FoÃ , R.; Aurelius, J.; Martner, A.; Hellstrand, K.; ThorÃ©n, F. B.

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia

2016 - EUROPEAN JOURNAL OF HAEMATOLOGY

Voso, Maria Teresa; Niscola, Pasquale; Piciocchi, Alfonso; Fianchi, Luana; Maurillo, Luca; Musto, Pellegrino; Pagano, Livio; Mansueto, Giovanna; Criscuolo, Marianna; ALOE SPIRITI, Maria Antonietta; Buccisano, Francesco; Venditti, Adriano; Tendas, Andrea; Piccioni, Anna Lina; Zini, Gina; Latagliata, Roberto; Filardi, Nunzio; Fragasso, Alberto; Fenu, Susanna; Breccia, Massimo

Gemtuzumab ozogamicin versus best supportive care in older patients with newly diagnosed acute myeloid leukemia unsuitable for intensive chemotherapy: Results of the randomized phase III EORTC-GIMEMA AML-19 Trial

2016 - JOURNAL OF CLINICAL ONCOLOGY

Amadori, Sergio; Venditti, Adriano; Voso, Maria Teresa; Annino, Luciana; De Fabritiis, Paolo; Alimena, Giuliana; Mancini, Marco; Paoloni, Francesca; Vignetti, Marco; Fazi, Paola; Aversa, Franco; Gaidano, Gainluca; Musso, Maurizio; Mazzone, Carla; Magro, Domenico; Ramadan, Safaa Mahmoud; Suciu, Stefan; Meert, Liv; Selleslag, Dominik; Hagemeijer, Anne; Baron, FrÃ©dÃ©ric; Muus, Petra; Dewitte, Theo; Willemze, Roel

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies

2015 - ANNALS OF HEMATOLOGY

Oosterveld, M; Suciu, S; Muus, P; Germing, U; Delforge, M; Belhabri, A; Aul, C; Selleslag, D; Ferrant, A; Marie, Jp; Amadori, S; Jehn, U; Mandelli, F; Hess, U; HellstrÃ¶m-Lindberg, E; Cakmak-Wollgast, S; Vignetti, M; Labar, B; Willemze, R; de Witte, T.

Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: A retrospective multicenter study

2015 - LEUKEMIA & LYMPHOMA

Parasole, Rosanna; Petruzziello, Fara; Messina, Chiara; Barisone, Elena; Pession, Andrea; Locatelli, Franco; Micalizzi, Concetta; Cesaro, Simone; Testi, Anna Maria; De Matteo, Antonia; Varotto, Stefania; Berger, Massimo; Morello, William; Menna, Giuseppe; Poggi, Vincenzo